4.7 Review

Leishmaniasis: drugs in the clinic, resistance and new developments

Journal

DRUG RESISTANCE UPDATES
Volume 7, Issue 4-5, Pages 257-266

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.drup.2004.07.002

Keywords

Leishmania; leishmaniasis; kala azar; pentavalent antimonials; stibogluconate; Pentostam; meglumine antimoniate; Glucantime; pentamidine; amphotericin B; miltefosine; fluconazole; ABC transporters

Ask authors/readers for more resources

The control of Leishmania infections relies primarily on chemotherapy. The arsenal of drugs available for treating Leishmania infections is limited and includes pentavalent antimonials, pentamidine, amphotericin B, miltefosine, fluconazole and few other drugs at various stages of their development process. In this review, we will discuss the latest results regarding resistance mechanisms to drugs used in the clinic against Leishmania infections. (C) 2004 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available